0.15% azelastine hydrochloride

DRUG4 trials

Sponsors

Meda Pharmaceuticals

Conditions

Perennial Allergic RhinitisSeasonal Allergic Rhinitis

Phase 3

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies

CompletedNCT00660829

Meda PharmaceuticalsSeasonal Allergic Rhinitis

Start: 2007-12-31End: 2008-04-30Updated: 2015-04-13

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergies

CompletedNCT00712920

Meda PharmaceuticalsPerennial Allergic Rhinitis

Start: 2007-01-31Updated: 2011-06-08

A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis

CompletedNCT00720382

Meda PharmaceuticalsPerennial Allergic Rhinitis

Start: 2007-03-31End: 2008-07-31Updated: 2015-05-21

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies

CompletedNCT00824473

Meda PharmaceuticalsSeasonal Allergic Rhinitis

Start: 2008-12-31End: 2009-02-28Updated: 2010-02-23

Related Papers

In perennial allergic rhinitis, RQLQ is improved similarly by Azelastine 0.15 and mometasone furoate

World Allergy Organization Journal2025-01-012 citations

A double-blind, placebo-controlled trial of the efficacy and safety of two doses of azelastine hydrochloride in perennial allergic rhinitis

Frontiers in Allergy2023-10-185 citations